LORENZO GALANTE: Open Payments
NPI 1023180726 · NORTH HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,330 in 193 payments from 36 companies in 2025. Trend: 2023 $4,402 · 2024 $4,942 · 2025 $4,330
Food & beverage: $4,288Education: $43
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $379 |
| Lilly USA, LLC | 10 | $347 |
| Novo Nordisk Inc | 20 | $333 |
| Indivior Inc. | 9 | $269 |
| ABBVIE INC. | 12 | $261 |
| Lundbeck LLC | 10 | $256 |
| GlaxoSmithKline, LLC. | 12 | $236 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $220 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $207 |
| Bayer Healthcare Pharmaceuticals Inc. | 22 | $187 |
Products named: JARDIANCE, REXULTI, SUBLOCADE, Wegovy, BREZTRI, TRELEGY ELLIPTA, Kerendia, TRINTELLIX.
Industry payments across CT — which companies pay providers there.
